{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:42:20Z","timestamp":1780663340803,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:00:00Z","timestamp":1567555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005999","name":"Bangladesh Council of Scientific and Industrial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010156","name":"Netherlands Leprosy Relief","doi-asserted-by":"publisher","award":["702.02.73"],"award-info":[{"award-number":["702.02.73"]}],"id":[{"id":"10.13039\/100010156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009425","name":"Q.M. Gastmann-Wichers Stichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009441","name":"Order of Malta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009441","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ijid.2019.08.035","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T11:40:36Z","timestamp":1567770036000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Effectiveness of single-dose rifampicin after BCG vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: A cluster randomized controlled trial"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4436-5066","authenticated-orcid":false,"given":"Renate","family":"Richardus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khorshed","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kallyan","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Chandra Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasnuva","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu Sufian","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"Nieboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ruth","family":"Butlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Geluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Hendrik","family":"Richardus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2019.08.035_bib0005","first-page":"1","article-title":"WHO expert committee on leprosy","volume":"874","author":"Anonymous","year":"1998","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"3","key":"10.1016\/j.ijid.2019.08.035_bib0010","article-title":"Global strategy for further reducing the leprosy burden and sustaining leprosy control activities 2006-2010. Operational guidelines","volume":"77","author":"Anonymous","year":"2006","journal-title":"Lepr Rev"},{"key":"10.1016\/j.ijid.2019.08.035_bib0015","series-title":"Bangladesh bureau of statistics: Bangladesh population & housing census 2011","author":"Anonymous","year":"2011"},{"issue":"35","key":"10.1016\/j.ijid.2019.08.035_bib0020","first-page":"501","article-title":"Global leprosy update, 2016: accelerating reduction of disease burden","volume":"92","author":"Anonymous","year":"2017","journal-title":"Releve Epidemiol Hebd"},{"key":"10.1016\/j.ijid.2019.08.035_bib0025","series-title":"Guidelines for the diagnosis, treatment and prevention of leprosy","author":"Anonymous","year":"2017"},{"issue":"93","key":"10.1016\/j.ijid.2019.08.035_bib0030","first-page":"445","article-title":"Global leprosy update, 2017: reducing the disease burden due to leprosy","volume":"35","author":"Anonymous","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.ijid.2019.08.035_bib0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.ijid.2019.08.035_bib0040","first-page":"389","article-title":"BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-79","volume":"67","author":"Bagshawe","year":"1989","journal-title":"Bull World Health Organ"},{"issue":"11","key":"10.1016\/j.ijid.2019.08.035_bib0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013633","article-title":"Leprosy post-exposure prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin","volume":"6","author":"Barth-Jaeggi","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijid.2019.08.035_bib0050","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fimmu.2018.00308","article-title":"Vaccines for leprosy and tuberculosis: opportunities for shared research, development, and application","volume":"9","author":"Coppola","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ijid.2019.08.035_bib0055","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1371\/journal.pntd.0000167","article-title":"BCG revaccination does not protect against leprosy in the Brazilian Amazon: a cluster randomised trial","volume":"2","author":"Cunha","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.ijid.2019.08.035_bib0060","first-page":"399","article-title":"Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren","volume":"7","author":"Dourado","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"10.1016\/j.ijid.2019.08.035_bib0065","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.trstmh.2008.04.015","article-title":"Effectiveness of BCG vaccination among leprosy contacts: a cohort study","volume":"102","author":"Duppre","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2019.08.035_bib0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41541-018-0050-z","article-title":"LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection","volume":"3","author":"Duthie","year":"2018","journal-title":"NPJ Vaccines"},{"issue":"3","key":"10.1016\/j.ijid.2019.08.035_bib0075","doi-asserted-by":"crossref","first-page":"292","DOI":"10.47276\/lr.83.3.292","article-title":"Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh","volume":"83","author":"Feenstra","year":"2012","journal-title":"Lepr Rev"},{"issue":"8986","key":"10.1016\/j.ijid.2019.08.035_bib0080","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ijid.2019.08.035_bib0085","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0035-9203(88)90003-X","article-title":"Leprosy in Malawi. 2. Background, design and prospects of the Karonga Prevention Trial, a leprosy vaccine trial in northern Malawi","volume":"82","author":"Fine","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2019.08.035_bib0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.smim.2018.06.003","article-title":"Correlates of immune exacerbations in leprosy","volume":"39","author":"Geluk","year":"2018","journal-title":"Semin Immunol"},{"issue":"2","key":"10.1016\/j.ijid.2019.08.035_bib0095","first-page":"84","article-title":"Complications of bacille Calmette-Guerin (BCG) vaccination and immunotherapy and their management","volume":"1","author":"Grange","year":"1998","journal-title":"Commun Dis Public Health"},{"issue":"2","key":"10.1016\/j.ijid.2019.08.035_bib0100","first-page":"179","article-title":"BCG-induced activations","volume":"28","author":"HW W","year":"1960","journal-title":"Int J Lepr"},{"issue":"9019","key":"10.1016\/j.ijid.2019.08.035_bib0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(96)02166-6","article-title":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group","volume":"348","author":"Karonga Prevention Trial Group","year":"1996","journal-title":"Lancet"},{"issue":"43","key":"10.1016\/j.ijid.2019.08.035_bib0110","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ijid.2019.08.035_bib0115","first-page":"465","article-title":"The rate of adverse events following BCG vaccination in Poland","volume":"66","author":"Krysztopa-Grzybowska","year":"2012","journal-title":"Przegl Epidemiol"},{"issue":"6342","key":"10.1016\/j.ijid.2019.08.035_bib0120","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1126\/science.356.6342.999","article-title":"India resurrects forgotten leprosy vaccine","volume":"356","author":"Kumar","year":"2017","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ijid.2019.08.035_bib0125","first-page":"1069","article-title":"BCG vaccination of children against leprosy: fourteen-year findings of the trial in Burma","volume":"63","author":"Lwin","year":"1985","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.ijid.2019.08.035_bib0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/erv.09.161","article-title":"BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control","volume":"9","author":"Merle","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.ijid.2019.08.035_bib0135","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/499278","article-title":"Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy","volume":"193","author":"Moet","year":"2006","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2019.08.035_bib0140","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1371\/journal.pntd.0000198","article-title":"The prevalence of previously undiagnosed leprosy in the general population of northwest bangladesh","volume":"2","author":"Moet","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"7647","key":"10.1016\/j.ijid.2019.08.035_bib0145","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/bmj.39500.885752.BE","article-title":"Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial","volume":"336","author":"Moet","year":"2008","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.ijid.2019.08.035_bib0150","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tim.2012.06.002","article-title":"New pathways of protective and pathological host defense to mycobacteria","volume":"20","author":"Ottenhoff","year":"2012","journal-title":"Trends Microbiol"},{"issue":"1","key":"10.1016\/j.ijid.2019.08.035_bib0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clindermatol.2014.07.009","article-title":"Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis (vaccination)","volume":"33","author":"Richardus","year":"2015","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.ijid.2019.08.035_bib0160","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/1471-2334-13-456","article-title":"The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study)","volume":"13","author":"Richardus","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"13","key":"10.1016\/j.ijid.2019.08.035_bib0165","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.vaccine.2015.02.017","article-title":"Clinical manifestations of leprosy after BCG vaccination: an observational study in Bangladesh","volume":"33","author":"Richardus","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2019.08.035_bib0170","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3389\/fimmu.2018.00629","article-title":"BCG and adverse events in the context of leprosy","volume":"9","author":"Richardus","year":"2018","journal-title":"Front Immunol"},{"issue":"50","key":"10.1016\/j.ijid.2019.08.035_bib0175","doi-asserted-by":"crossref","first-page":"7125","DOI":"10.1016\/j.vaccine.2009.09.054","article-title":"Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention","volume":"27","author":"Schuring","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ijid.2019.08.035_bib0180","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1473-3099(06)70412-1","article-title":"The role of BCG in prevention of leprosy: a meta-analysis","volume":"6","author":"Setia","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2019.08.035_bib0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.47276\/lr.76.2.127","article-title":"Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years","volume":"76","author":"Sharma","year":"2005","journal-title":"Lepr Rev"},{"key":"10.1016\/j.ijid.2019.08.035_bib0190","doi-asserted-by":"crossref","first-page":"102","DOI":"10.47276\/lr.89.2.102","article-title":"The Leprosy Post-Exposure Prophylaxis (LPEP) programme: update and interim analysis","volume":"89","author":"Steinmann","year":"2018","journal-title":"Lepr Rev"},{"issue":"4","key":"10.1016\/j.ijid.2019.08.035_bib0195","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/338462","article-title":"National study of adverse reactions after vaccination with bacille Calmette-Guerin","volume":"34","author":"Turnbull","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2019.08.035_bib0200","unstructured":"UNAIDS https:\/\/aidsdatahub.org\/sites\/default\/files\/country_review\/Bangladesh-2019-UNAIDS-data.pdf (Accessed 30 September 2019)."},{"key":"10.1016\/j.ijid.2019.08.035_bib0205","doi-asserted-by":"crossref","first-page":"34260","DOI":"10.1038\/srep34260","article-title":"Quantitative lateral flow strip assays as user-friendly tools to detect biomarker profiles for leprosy","volume":"6","author":"van Hooij","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ijid.2019.08.035_bib0210","doi-asserted-by":"crossref","first-page":"17920","DOI":"10.1038\/s41598-018-36323-1","article-title":"Evaluation of Immunodiagnostic Tests for Leprosy in Brazil, China and Ethiopia","volume":"8","author":"van Hooij","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2019.08.035_bib0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.08.009","article-title":"Application of new host biomarker profiles in quantitative point-of-care tests facilitates leprosy diagnosis in the field","author":"van Hooij","year":"2019","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.ijid.2019.08.035_bib0220","article-title":"Genome sequencing and analysis of BCG vaccine strains","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219303650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219303650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:24:31Z","timestamp":1778592271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971219303650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":44,"alternative-id":["S1201971219303650"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2019.08.035","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of single-dose rifampicin after BCG vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: A cluster randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2019.08.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}